KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) EBT Margin (2016 - 2025)

Globus Medical (GMED) has disclosed EBT Margin for 15 consecutive years, with 20.48% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin rose 1673.0% year-over-year to 20.48%, compared with a TTM value of 20.59% through Dec 2025, up 1580.0%, and an annual FY2025 reading of 20.59%, up 1580.0% over the prior year.
  • EBT Margin was 20.48% for Q4 2025 at Globus Medical, up from 18.72% in the prior quarter.
  • Across five years, EBT Margin topped out at 26.76% in Q2 2022 and bottomed at 67.45% in Q4 2022.
  • Average EBT Margin over 5 years is 11.75%, with a median of 19.11% recorded in 2025.
  • The sharpest move saw EBT Margin tumbled -7538bps in 2022, then soared 7150bps in 2023.
  • Year by year, EBT Margin stood at 7.93% in 2021, then plummeted by -950bps to 67.45% in 2022, then soared by 106bps to 4.05% in 2023, then decreased by -7bps to 3.75% in 2024, then soared by 446bps to 20.48% in 2025.
  • Business Quant data shows EBT Margin for GMED at 20.48% in Q4 2025, 18.72% in Q3 2025, and 25.25% in Q2 2025.